NASDAQ: IBRXImmunitybio Inc Stock Ownership - Who owns Immunitybio?
Insider buying vs selling
Have Immunitybio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Patrick Soonshiong | Founder Executive Chairman Global Chief Scientific and Medical Officer | 2026-03-31 | 4,606,596 | $5.43 | $25.00MBuy |
| Barry J. Simon | Director | 2026-02-24 | 75,000 | $12.01 | $900.83kSell |
| Christobel Selecky | Director | 2026-02-23 | 25,000 | $2.98 | $74.50kBuy |
| Barry J. Simon | Director | 2026-02-23 | 165,000 | $10.25 | $1.69MSell |
| Christobel Selecky | Director | 2026-02-23 | 25,000 | $10.00 | $250.00kSell |
| Richard Adcock | CEO President | 2026-02-22 | 77,560 | $8.70 | $674.77kSell |
| Barry J. Simon | Director | 2026-02-22 | 6,026 | $8.70 | $52.43kSell |
| Regan J. Lauer | Chief Accounting Officer | 2026-02-22 | 1,673 | $8.70 | $14.56kSell |
| David C. Sachs | Chief Financial Officer | 2026-02-22 | 20,682 | $8.70 | $179.93kSell |
| Patrick Soonshiong | Founder Executive Chairman Global Chief Scientific and Medical Officer | 2026-02-22 | 58,170 | $8.70 | $506.08kSell |
IBRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IBRX insiders and whales buy or sell their stock.
IBRX Shareholders
What type of owners hold Immunitybio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Patrick Soonshiong | 6.72% | 70,341,055 | $545.85M | Insider |
| Blackrock Inc | 2.52% | 26,346,443 | $204.45M | Institution |
| State Street Corp | 1.69% | 17,708,103 | $137.41M | Institution |
| Vanguard Portfolio Management LLC | 1.56% | 16,322,844 | $126.67M | Institution |
| Vanguard Capital Management LLC | 1.44% | 15,127,714 | $117.39M | Institution |
| D E Shaw Co Inc | 1.20% | 12,571,597 | $97.56M | Institution |
| Geode Capital Management LLC | 0.77% | 8,031,921 | $62.33M | Institution |
| Two Sigma Investments LP | 0.42% | 4,385,500 | $34.03M | Institution |
| Morgan Stanley | 0.38% | 4,018,869 | $31.19M | Institution |
| Hrt Financial LP | 0.37% | 3,925,446 | $30.46M | Institution |
IBRX vs Biotech Stocks
Immunitybio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.